Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  














3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol
Clinical data
Other names3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol
Identifiers
  • (8R,9S,10S,13S,14S,17S)-10-Ethenyl-3,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-ol

PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H30O
Molar mass298.470 g·mol−1
3D model (JSmol)
  • CC1=CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@]2(CC1)C=C)C)O

  • InChI=1S/C21H30O/c1-4-21-12-9-14(2)13-15(21)5-6-16-17-7-8-19(22)20(17,3)11-10-18(16)21/h4-5,13,16-19,22H,1,6-12H2,2-3H3/t16-,17-,18-,19-,20-,21-/m0/s1

  • Key:PPGVWCDLIZEUNC-PXQJOHHUSA-N

3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol is a synthetic, steroidal estrogen and a selective agonist of the ERβ.[1] It was discovered serendipitously and was the lead compound among a series of androsta-3,5-dienes as ERβ ligands.[1][2] Its affinity (IC50) for the ERβ was found to be 9 nM and it showed 62- and 160-fold binding selectivity for this receptor over the ARTooltip androgen receptor and the ERα, respectively.[1] The EC50 of the compound for the ERβ was found to be 69 nM and its intrinsic activity was 92% (relative to that of estradiol).[1] As such, it is a potent ERβ agonist with high affinity and selectivity.[1]

References[edit]

  1. ^ a b c d e Blizzard TA, Gude C, Morgan JD, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Rohrer SP, Hammond ML (2007). "Androstene-3,5-dienes as ER-beta selective SERMs". Bioorg. Med. Chem. Lett. 17 (22): 6295–8. doi:10.1016/j.bmcl.2007.09.001. PMID 17890084.
  • ^ Khalil RA (2013). "Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease". Biochem. Pharmacol. 86 (12): 1627–42. doi:10.1016/j.bcp.2013.09.024. PMC 3840081. PMID 24099797.

  • t
  • e
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol&oldid=1150120874"

    Categories: 
    Secondary alcohols
    Androstanes
    Selective ERβ agonists
    Synthetic estrogens
    Steroid stubs
    Genito-urinary system drug stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Chemical articles without CAS registry number
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Articles without UNII source
    Drugs missing an ATC code
    Drugs with no legal status
    Articles containing unverified chemical infoboxes
    All stub articles
     



    This page was last edited on 16 April 2023, at 12:21 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki